The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid-19.
Amal F AlshammaryHassan M AlQarniRaed FarzanImran Ali KhanVishal VennuPublished in: The clinical respiratory journal (2023)
VTE risk and blood hyperlactatemia have been associated with a higher mortality risk in critically ill Covid-19 patients who are hospitalized in the ICU in Saudi Arabia. According to our findings, these people needed more effective VTE prevention strategies based on a personalized assessment of their risk of bleeding. Moreover, persons without diabetes and other groups with a high risk of dying from COVID-19 may be recognized by measuring glucose as having elevated glucose and lactate jointly.
Keyphrases
- venous thromboembolism
- sars cov
- direct oral anticoagulants
- blood glucose
- coronavirus disease
- type diabetes
- intensive care unit
- cardiovascular disease
- palliative care
- atrial fibrillation
- glycemic control
- cardiovascular events
- respiratory syndrome coronavirus
- weight loss
- metabolic syndrome
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome